EP 0942916 A2 19990922 - NUCLEOSIDES
Title (en)
NUCLEOSIDES
Title (de)
NUKLEOSIDE
Title (fr)
NUCLEOSIDES
Publication
Application
Priority
- SE 9701903 W 19971112
- SE 9604165 A 19961112
- SE 9604154 A 19961112
- SE 9702957 A 19970815
- US 79821897 A 19970210
- US 91292797 A 19970815
Abstract (en)
[origin: WO9821223A1] Mixed esters of antiviral nucleosides such as compounds of Formula (I), where B is natural or unnatural nucleotide base, X is O or CH2, Y and Z are each H, or together form a bond, or Y is methylene or -CH(OH)- and Z is a bond thereto; n is 0 or 1; one of R1 and R2 is the acyl residue of an aliphatic amino acid and the other is -C(=O)C5-C21 saturated or monounsaturated alkyl; and pharmaceutically acceptable salts thereof have advantageous pharmacokinetic and other properties.
IPC 1-7
C07H 19/06; C07H 19/067; C07H 19/16; C07H 19/167; C07D 473/18; C07D 473/32; C07D 473/34; A61K 31/52; A61K 31/70
IPC 8 full level
C07D 473/18 (2006.01); A61K 31/522 (2006.01); A61K 31/7056 (2006.01); A61K 31/7068 (2006.01); A61K 31/708 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); C07D 473/00 (2006.01); C07H 19/04 (2006.01); C07H 19/056 (2006.01); C07H 19/06 (2006.01); C07H 19/09 (2006.01); C07H 19/16 (2006.01); C07H 19/19 (2006.01); C07B 61/00 (2006.01)
CPC (source: EP KR)
A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); C07D 473/00 (2013.01 - EP); C07H 19/04 (2013.01 - EP); C07H 19/06 (2013.01 - KR); C07H 19/16 (2013.01 - EP); C40B 40/00 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9821223 A1 19980522; AU 5075998 A 19980603; AU 735438 B2 20010705; CA 2271135 A1 19980522; EP 0942916 A2 19990922; JP 2001503767 A 20010321; KR 20000053226 A 20000825
DOCDB simple family (application)
SE 9701903 W 19971112; AU 5075998 A 19971112; CA 2271135 A 19971112; EP 97913620 A 19971112; JP 52248098 A 19971112; KR 19997004201 A 19990512